Petra Seeholzer

Learn More
BACKGROUND Symptoms of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) can overlap. We aimed to determine the accuracy of fecal markers, C-reactive protein (CRP), blood leukocytes, and antibody panels for discriminating IBD from IBS and to define a "best test." METHODS We prospectively included 64 patients with IBD (36 Crohn's disease(More)
PURPOSE This study was designed to evaluate the accuracy of four different fecal markers in discriminating between irritable bowel syndrome, inflammatory bowel disease, and other forms of colitis and to examine the feasibility of collecting fecal samples in outpatients. METHODS We prospectively included 20 patients with irritable bowel syndrome, 36 with(More)
  • 1